CAPALBO, Carlo
 Distribuzione geografica
Continente #
AS - Asia 3.058
NA - Nord America 2.513
EU - Europa 724
SA - Sud America 700
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 4
Totale 7.228
Nazione #
US - Stati Uniti d'America 2.347
SG - Singapore 1.236
CN - Cina 620
BR - Brasile 496
VN - Vietnam 453
HK - Hong Kong 290
IT - Italia 280
FR - Francia 123
KR - Corea 80
AR - Argentina 79
BD - Bangladesh 79
CA - Canada 51
IN - India 50
DE - Germania 45
FI - Finlandia 45
GB - Regno Unito 44
IQ - Iraq 44
MX - Messico 44
NL - Olanda 43
ZA - Sudafrica 38
EC - Ecuador 34
ID - Indonesia 31
RU - Federazione Russa 28
CO - Colombia 27
PK - Pakistan 27
UZ - Uzbekistan 23
MA - Marocco 20
PL - Polonia 18
TN - Tunisia 17
PY - Paraguay 16
TR - Turchia 16
UA - Ucraina 15
VE - Venezuela 15
JP - Giappone 14
CZ - Repubblica Ceca 13
CL - Cile 12
CR - Costa Rica 11
MY - Malesia 11
SE - Svezia 11
HN - Honduras 9
NI - Nicaragua 9
SA - Arabia Saudita 9
BO - Bolivia 8
CW - ???statistics.table.value.countryCode.CW??? 8
DZ - Algeria 8
ES - Italia 8
PH - Filippine 8
EG - Egitto 7
ET - Etiopia 7
PA - Panama 7
SV - El Salvador 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BH - Bahrain 6
KE - Kenya 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
IL - Israele 5
JM - Giamaica 5
JO - Giordania 5
LT - Lituania 5
NP - Nepal 5
PE - Perù 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
GP - Guadalupe 4
GT - Guatemala 4
LB - Libano 4
MD - Moldavia 4
OM - Oman 4
SC - Seychelles 4
SY - Repubblica araba siriana 4
AO - Angola 3
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
EE - Estonia 3
KZ - Kazakistan 3
PR - Porto Rico 3
RO - Romania 3
RS - Serbia 3
AT - Austria 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
MU - Mauritius 2
SI - Slovenia 2
SN - Senegal 2
SR - Suriname 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
Totale 7.104
Città #
Singapore 549
San Jose 409
Council Bluffs 329
Ashburn 322
Hong Kong 286
Boardman 214
Beijing 197
Dallas 193
Ho Chi Minh City 170
Hefei 137
Hanoi 81
Seoul 78
Lauterbourg 75
Santa Clara 59
Milan 49
São Paulo 47
New York 39
Los Angeles 38
Helsinki 37
The Dalles 36
Ogden 34
Rome 30
West Jordan 22
Amsterdam 21
Miano 21
Abbeville 20
Atlanta 20
Chicago 20
Da Nang 20
Haiphong 19
Frankfurt am Main 18
Johannesburg 18
Secaucus 18
Tashkent 18
Phoenix 17
Longmont 16
Montreal 16
Orem 16
Brooklyn 15
Mexico City 15
Baghdad 14
Chennai 13
Warsaw 13
Biên Hòa 12
Boston 12
Shanghai 12
Guayaquil 11
Irvine 11
Munich 11
Naples 11
Tianjin 11
Brno 10
Curitiba 10
Dhaka 10
Falkenstein 10
Omaha 10
Quito 10
Tokyo 10
Brasília 9
Buenos Aires 9
Hải Dương 9
Managua 9
Medellín 9
Princeton 9
San Antonio 9
San Francisco 9
San José 9
Stockholm 9
Toronto 9
Asunción 8
Belo Horizonte 8
Erbil 8
Ninh Bình 8
Thái Nguyên 8
Willemstad 8
Campinas 7
Guangzhou 7
Porto Alegre 7
San Salvador 7
Addis Ababa 6
Bogotá 6
Casablanca 6
Córdoba 6
Fortaleza 6
London 6
Nairobi 6
Nha Trang 6
North Bergen 6
Quảng Ngãi 6
Rio de Janeiro 6
São Bernardo do Campo 6
Thái Bình 6
Tunis 6
Turin 6
Ankara 5
Baku 5
Buffalo 5
Cosenza 5
Duque de Caxias 5
Durban 5
Totale 4.235
Nome #
Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC) 186
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer 158
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients 157
Sistema stabile di coltura in vitro di cellule precursori granulari cerebellari (GCP), metodo stabile per la coltura in vitro di dette cellule e usi di detto sistema o metodo per la coltura in vitro 148
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis 114
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 107
H-Ras gene takes part to the host immune response to COVID-19 105
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software 98
Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation 98
Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes 98
High-throughput microRNA profiling of pediatric high-grade gliomas 97
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 96
Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer 95
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 95
BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors 94
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP 93
Bioelectrical Impedance Analysis (BIA) to measure alterations on hydroelectrolytic equilibrium of peripheral cells in COVID-19 patients with nonthyroidal illness syndrome (NTIS) 93
A case of long surviving metastatic retroperitoneal epithelioid sarcoma in a 20 year old male 92
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report 92
microRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1 91
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 90
CT based radiomic approach on first line pembrolizumab in lung cancer 90
PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma 90
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 89
A novel BRCA2 splice variant identified in a young woman 89
Cancer secretome and inflammation: The bright and the dark sides of NF-κB 89
Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants 88
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer. A novel mechanism of intrinsic drug resistance 88
PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress 88
Beyond BRCA1 and BRCA2: deleterious variants in DNA repair pathway genes in italian families with breast/ovarian and pancreatic cancers 88
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 87
NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest 87
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models 87
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 85
HER2-positive male breast cancer: an update 85
Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview 85
Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma 83
Male breast cancer 82
The impact of searching for BRCA1/2 large genomic rearrangement on BRCAPRO carrier prediction 82
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study 82
Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain 82
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families 81
Weekly Paclitaxel-carboplatin As Front-line Chemotherapy In Elderly Patients With Locally Advanced/metastatic (stage Iiib-iv) Non-small-cell Lung Cancer. A Phase Ii Study 81
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors 81
P.04.4 PRESENTATION SYMPTOMS AND RISK FACTORS ARE ASSOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH SURVIVAL OF PATIENTS WITH PANCREATIC CANCER 81
Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond 81
Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy 81
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D) 80
Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer 79
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis 79
Gynecological and reproductive factors and the risk of pancreatic cancer. a case-control study 77
Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14 75
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100) 75
The role of peroxiredoxins in cancer 74
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms 74
Unique pineal gland metastasis of clear cell renal carcinoma: case report and review of the literature 73
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 73
No evidence of sars-cov-2 circulation in rome (Italy) during the pre-pandemic period. Results of a retrospective surveillance 73
Diagnostic delay does not influence survival of pancreatic cancer patients 72
Severe acute respiratory infections (SARI) surveillance in over-65-years-old patients: the experience of a University hospital (seasons 2017-2018 and 2018-2019) 72
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 71
Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium 70
Phenformin inhibits hedgehog-dependent tumor growth through a complex i-independent redox/corepressor module 70
Immunohistochemical expression of Dicer in melanoma 70
Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data 70
Does the search for large genomic Rearrangements impact BRCAPRO carrier prediction? 70
Opposite effect of thyroid hormones on oxidative stress and on mitochondrial respiration in COVID-19 patients 69
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance 69
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 69
Predictive biomarkers for checkpoint inhibitor-based immunotherapy: The Galectin-3 signature in NSCLCs 69
Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy 68
Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma 67
Identification of families selected for breast cancer predisposition risk and showing low rate of BRCA1/BRCA2 mutations (< 10%) 67
Next-generation sequencing: recent applications to the analysis of colorectal cancer 66
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach 66
Hierarchical convolutional models for automatic pneumonia diagnosis based on X-ray images: new strategies in public health 65
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 65
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families 64
Effect of MTHFR polymorphisms on gastrointestinal cancer risk in Italy 63
The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care Pathway 62
Nonthyroidal illness syndrome. to treat or not to treat? Have we answered the question? A review of metanalyses 61
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model 60
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients 58
The end of the beginning of personalized medicine 46
HER2-Low Expression in Male Breast Cancer: Results from a Multicenter Series in Italy 46
Alternate actions of CDK4/6 inhibitors beyond cell cycle blockade: unexplored roles in therapy resistance 36
Glioblastoma cancer: comparing the effectiveness of 3D conformal radiation therapy and volumetric modulated radiotherapy an artificial intelligence-based survival prediction 28
The Thermal Ablation with MRgFUS: From Physics to Oncological Applications 25
Thymic-Epithelial-Cell-Dependent Microenvironment Influences Proliferation and Apoptosis of Leukemic Cells 17
Transcriptomic deconvolution reveals prognostic immune signatures and immunotherapy-responsive subtypes in male breast cancer 16
Totale 7.228
Categoria #
all - tutte 35.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024340 0 0 0 0 0 0 0 98 58 46 10 128
2024/20251.528 86 181 13 42 77 99 82 52 222 91 140 443
2025/20264.274 546 310 399 355 693 260 556 208 279 326 123 219
2026/20271.086 232 93 210 551 0 0 0 0 0 0 0 0
Totale 7.228